findmyKOL

Kris Kowdley, MD

Enriched profile

Director, Liver Institute Northwest; Professor, Elson S. Floyd College of Medicine, Washington State University; Senior Scientific Advisor and Medical Director, Velocity Clinical Research · Washington State University

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Seattle, WA · West · United StatesSpecialtyGastroenterologyFocusLiver Disease Diagnosis and Treatment+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1997–2026

Kris Kowdley is Director, Liver Institute Northwest; Professor, Elson S. Floyd College of Medicine, Washington State University; Senior Scientific Advisor and Medical Director, Velocity Clinical Research at Washington State University. OpenAlex indexes 1,017 publications with 67,013 citations (h-index 119); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Gastroenterology profiles in the findmyKOL directory. Clarivate lists Kris Kowdley as a Highly Cited Researcher (Clinical Medicine, 2019-2024).

Data verified 17 Oct 2026

Overview

Updated 18 Oct 2026

Kris V. Kowdley, MD, is Director, Liver Institute Northwest at Washington State University (Elson S. Floyd College of Medicine). The public record shows 1,017 publications with 67,013 citations (h-index 119), centered on Liver Disease Diagnosis and Treatment, Liver Diseases and Immunity, Hepatitis C virus research. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 33 companies, 12 NIH-funded awards (1997–2026).

  • Most recent indexed publication: 2026 · Hepatology communications
  • Top research focus: Liver Disease Diagnosis and Treatment
  • 7 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 33 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Non-alcoholic Fatty Liver Disease4 trialsFatty Liver4 trialsFatty Liver, Alcoholic4 trialsViral Hepatitis (B/C)1 trialHepatitis C1 trialHepatitis C, Chronic1 trialDiabetes Mellitus1 trialCholangitis, Sclerosing1 trialCholangitis1 trial

Research focus

OpenAlex concept fingerprint
Liver Disease Diagnosis and TreatmentLiver Diseases and ImmunityHepatitis C virus researchLiver Disease and TransplantationIron Metabolism and Disorders

Drugs & molecules

across trials, industry payments and publications
Ocalivageneric · Obeticholic acidClinical trials—Industry payments93Publications4Rezdiffrageneric · ResmetiromClinical trials—Industry payments52Publications1Livdelzigeneric · SeladelparClinical trials—Industry payments24Publications2Epclusageneric · Sofosbuvir / velpatasvirClinical trials—Industry payments70Publications—XIFAXANgeneric · RifaximinClinical trials—Industry payments22Publications—Iqirvogeneric · ElafibranorClinical trials—Industry payments20Publications—Livmarligeneric · MaralixibatClinical trials—Industry payments13Publications—Cuvriorgeneric · TrientineClinical trials—Industry payments7Publications—Wegovygeneric · SemaglutideClinical trials—Industry payments7Publications—Bylvaygeneric · OdevixibatClinical trials—Industry payments6Publications—Terlivazgeneric · TerlipressinClinical trials—Industry payments5Publications—Korlymgeneric · MifepristoneClinical trials—Industry payments4Publications—

Works with

trial sponsors and companies reporting payments
Gilead Sciences, Inc.Clinical trials—Industry payments139Intercept Pharmaceuticals, Inc.Clinical trials—Industry payments98Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments60Madrigal PharmaceuticalsClinical trials—Industry payments52Novo Nordisk IncClinical trials—Industry payments49GlaxoSmithKline, LLC.Clinical trials—Industry payments38Ipsen Biopharmaceuticals, IncClinical trials—Industry payments32Salix Pharmaceuticals, a division of Bausch Health US, LLCClinical trials—Industry payments24Mirum Pharmaceuticals, Inc.Clinical trials—Industry payments23Mallinckrodt Hospital Products Inc.Clinical trials—Industry payments13Kowa Research Institute, Inc.Clinical trials—Industry payments12Ipsen Bioscience IncClinical trials—Industry payments10Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments9CSL BehringClinical trials—Industry payments7Ipsen InnovationClinical trials—Industry payments7Orphalan IncClinical trials—Industry payments7Abbvie Inc.Clinical trials—Industry payments6Corcept TherapeuticsClinical trials—Industry payments5Merck Sharp & Dohme LLCClinical trials—Industry payments5Boehringer Ingelheim International GmbHClinical trials—Industry payments4Albireo Pharma, Inc.Clinical trials—Industry payments3AstraZeneca Pharmaceuticals LPClinical trials—Industry payments3GlaxoSmithKlineClinical trials2Industry payments—Ipsen Pharma SASClinical trials—Industry payments2National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Clinical trials2Industry payments—Amgen Inc.Clinical trials—Industry payments1Echosens North America, Inc.Clinical trials—Industry payments1Eiger BioPharmaceuticals, Inc.Clinical trials—Industry payments1Eisai Inc.Clinical trials—Industry payments1LISCure BiosciencesClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,017publications

Distinct works indexed by OpenAlex, matched via ORCID; 21 in PubMed.

67,013citations

Total citations across indexed works.

119h-index

Hirsch index (OpenAlex). i10-index 414.

Clinical & industry

trials, payments and federal funding
7clinical trials

Investigator role on registered studies.

View trials ↓
33companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
12NIH grants · 1997–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:

All 7 trial records: search, sort and filter.Explore →

Industry payments

Updated 18 Oct 2026

33 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 74 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    100%
    Bile Acid100%
    Ursodiol100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 18 Oct 2026

12 NIH research awards on record, funded 1997–2026 per NIH RePORTER. The latest:

All 137 award records: search, sort and filter.Explore →

Congress activity

Updated 18 Oct 2026

4 congress contributions (2013–2025) across ASCO, ASH per OpenAlex. The most recent:

All 4 congress records: search, sort and filter.Explore →

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 18 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 21 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
    3,301 citations2010
    doi.org ↗
  2. 02
    A multisociety Delphi consensus statement on new fatty liver disease nomenclature
    2,939 citations2023
    doi.org ↗
  3. 03
    A multisociety Delphi consensus statement on new fatty liver disease nomenclature
    2,744 citations2023
    doi.org ↗
  4. 04
    Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
    2,189 citations2014
    doi.org ↗
  5. 05
    Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
    1,783 citations2013
    doi.org ↗
All 1,017 cited works: search, sort and filter.Explore →

Network

Updated 18 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Rohit Loomba84Gideon M. Hirschfield80Marlyn J. Mayo79Arun J. Sanyal74Eric Lawitz73Keith D. Lindor66Christopher L. Bowlus64Cynthia Levy63Geoffrey W. McCaughan58Christophe Corpechot57Christian Trautwein52Pietro Invernizzi50Zobair M. Younossi50Andrew L. Mason49Palak Trivedi48Albert Parés48Frederik Nevens47Douglas Thorburn46Harry L.A. Janssen46Annarosa Floreani44Bettina E. Hansen43Brent A. Neuschwander‐Tetri43Willem J. Lammers41Manal F. Abdelmalek41Stuart C. Gordon41Pier Maria Battezzati40Steven L. Flamm40James E. Nelson37George Ν. Dalekos36Tony Bruns36David E. Kleiner35Cyriel Y. Ponsioen35Naga Chalasani35Nezam H. Afdhal34Aliya Gulamhusein33Ira M. Jacobson32Stephen A. Harrison31Velimir A. Luketic30Xavier Verhelst29Zachary Goodman29

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/kris-kowdley-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/profile/Kris-Kowdley

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/KowdleyMd

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • LinkedIn

    linkedin.com/in/kris-kowdley-706ba3178

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

Mentions by others

where others cite or feature them
  • Other

    medicine.wsu.edu/news/2023/07/14/infection-rates

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wsu.edu ↗
  • X / Twitter

    X/Twitter handle @kowdleymd, "Kris V. Kowdley MD, AGAF, FAASLD, FACG, FACP, FASG"

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Director

    Liver Institute Northwest

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
  • Professor

    Elson S. Floyd College of Medicine, Washington State University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.org ↗
  • Senior Scientific Advisor and Medical Director

    Velocity Clinical Research

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →velocityclinical.com ↗
  • MASH CARE Council Leader

    Velocity Clinical Research

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →velocityclinical.com ↗

Highly Cited Researcher

Clarivate's annual list, by award category and year
  • Clinical Medicine
    201920202021202220232024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.